Skip to main content
Glama

PeptideCompare.co: US peptide and NAD+ clinic prices

FDA standing of a peptide

get_fda_status
Read-onlyIdempotent

Whether a peptide or NAD+ is FDA approved, and where it stands for compounding (503A categories, HHS's October 2026 policy), quoted from FDA pages with the address and day each was read, plus how much it has been tested in people (PubMed and ClinicalTrials.gov counts, and the conditions its registered studies examine), the reports to the FDA naming it, and the FDA recalls and warning letters naming it, each counted daily.

Tool call template

Replace each placeholder with a value matching the input schema. Only required parameters are included; add optional parameters as needed.

{
  "id": 1,
  "jsonrpc": "2.0",
  "method": "tools/call",
  "params": {
    "arguments": {
      "compound": "<compound>"
    },
    "name": "get_fda_status"
  }
}

Input Schema

NameRequiredDescriptionDefault
compoundYesA peptide, NAD+ or a peptide stack, in any common spelling: "NAD+", "BPC-157", "sermorelin", "CJC-1295 / ipamorelin", "GHK-Cu", "Wolverine stack".

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observed

TDQS

Score is being calculated.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources